These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11334867)

  • 1. Effects of dopaminergic agents on carrageenan hyperalgesia after intrathecal administration to rats.
    Gao X; Zhang Y; Wu G
    Eur J Pharmacol; 2001 Apr; 418(1-2):73-7. PubMed ID: 11334867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dopaminergic agents on carrageenan hyperalgesia in rats.
    Gao X; Zhang Y; Wu G
    Eur J Pharmacol; 2000 Oct; 406(1):53-8. PubMed ID: 11011033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a range of dopamine receptor agonists and antagonists on ethanol intake in the rat.
    Silvestre JS; O'Neill MF; Fernandez AG; Palacios JM
    Eur J Pharmacol; 1996 Dec; 318(2-3):257-65. PubMed ID: 9016913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic modulation of rat pup ultrasonic vocalizations.
    Dastur FN; McGregor IS; Brown RE
    Eur J Pharmacol; 1999 Oct; 382(2):53-67. PubMed ID: 10528139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.
    Collins GT; Witkin JM; Newman AH; Svensson KA; Grundt P; Cao J; Woods JH
    J Pharmacol Exp Ther; 2005 Jul; 314(1):310-9. PubMed ID: 15833897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice.
    Ralph RJ; Caine SB
    J Pharmacol Exp Ther; 2005 Feb; 312(2):733-41. PubMed ID: 15494551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
    Schmidt HD; Pierce RC
    Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased locomotor activity after microinjection of dopamine D2/D3 receptor agonists and antagonists into lobule 9/10 of the cerebellum: a D3 receptor mediated effect?
    Boulay D; Depoortere R; Perrault G; Sanger DJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Jan; 24(1):39-49. PubMed ID: 10659982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The behavioural effects of pramipexole, a novel dopamine receptor agonist.
    Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
    Eur J Pharmacol; 1997 Apr; 324(1):31-7. PubMed ID: 9137910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; turning behaviour.
    Koshikawa N; Kitamura M; Kobayashi M; Cools AR
    Eur J Pharmacol; 1996 Jul; 308(3):235-41. PubMed ID: 8858293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supraspinal D2 receptor involved in antinociception induced by l-tetrahydropalmatine.
    Hu JY; Jin GZ
    Zhongguo Yao Li Xue Bao; 1999 Aug; 20(8):715-9. PubMed ID: 10678104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    Eur J Pharmacol; 1994 Aug; 260(2-3):237-41. PubMed ID: 7988649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of dopamine receptors in beneficial effects of tachykinins on scopolamine-induced impairment of alternation performance in mice.
    Ukai M; Shinkai N; Kameyama T
    Eur J Pharmacol; 1998 May; 350(1):39-45. PubMed ID: 9683012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locomotor inhibition, yawning and vacuous chewing induced by a novel dopamine D2 post-synaptic receptor agonist.
    Smith HP; Nichols DE; Mailman RB; Lawler CP
    Eur J Pharmacol; 1997 Mar; 323(1):27-36. PubMed ID: 9105873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Existence of dopamine D1 receptor on the sympathetic nerve endings in the guinea-pig vas deferens.
    Furukawa T; Morishita H
    Eur J Pharmacol; 1997 Jun; 328(2-3):229-34. PubMed ID: 9218705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dopaminergic agents on antinociception in formalin test.
    Zarrindast MR; Nassiri-Rad S; Pazouki M
    Gen Pharmacol; 1999 Apr; 32(4):517-22. PubMed ID: 10323495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dopamine D(1) receptor agonist SKF-82958 serves as a discriminative stimulus in the rat.
    Haile CN; Carey G; Varty GB; Coffin VL
    Eur J Pharmacol; 2000 Jan; 388(2):125-31. PubMed ID: 10666503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D(1) receptor-mediated control of striatal acetylcholine release by endogenous dopamine.
    Acquas E; Di Chiara G
    Eur J Pharmacol; 1999 Oct; 383(2):121-7. PubMed ID: 10585525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine receptors in the anterior insular cortex modulate long-term nociception in the rat.
    Coffeen U; López-Avila A; Ortega-Legaspi JM; del Angel R; López-Muñoz FJ; Pellicer F
    Eur J Pain; 2008 Jul; 12(5):535-43. PubMed ID: 17936656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endomorphins 1 and 2 induce amnesia via selective modulation of dopamine receptors in mice.
    Ukai M; Lin HP
    Eur J Pharmacol; 2002 Jun; 446(1-3):97-101. PubMed ID: 12098590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.